BEAM vs IT · rev $63.5M vs P/E 16, rev $6.27B
Beam Therapeutics Inc (BEAM) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
BEAM currently screens at market cap $2.01B. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the BEAM and IT stock pages for the full models.
Not investment advice.